Disclosure Of First-Time Adoption [Text Block]

ABIONYX Pharma - Filing #2813091

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
7 169 EUR
2 726 EUR
192,000 EUR
8 599 EUR
229,000 EUR
1 418 EUR
126,000 EUR
201,000 EUR
169 829 EUR
10 677 EUR
10,000 EUR
179 214 EUR
87,000 EUR
1 396 EUR
5,000 EUR
39,000 EUR
1 232 EUR
6 629 EUR
164 822 EUR
170 322 EUR
136,000 EUR
Comprehensive income
3 985 EUR
5 759 EUR
Profit (loss)
4 206 EUR
4 206 EUR
5 822 EUR
5 822 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.